phosphoserine has been researched along with dehydroepiandrosterone in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gomez, GI; Moreno, M; Muñoz, YC; Solis, CL; Valladares, LE; Velarde, V | 1 |
1 other study(ies) available for phosphoserine and dehydroepiandrosterone
Article | Year |
---|---|
Dehydroepiandrosterone prevents the aggregation of platelets obtained from postmenopausal women with type 2 diabetes mellitus through the activation of the PKC/eNOS/NO pathway.
Topics: Blood Platelets; Cyclic GMP; Dehydroepiandrosterone; Diabetes Mellitus, Type 2; Enzyme Activation; Enzyme Inhibitors; Female; Humans; Middle Aged; Nitric Oxide; Nitric Oxide Synthase Type III; Phosphorylation; Phosphoserine; Platelet Aggregation; Postmenopause; Protein Kinase C-delta; Signal Transduction | 2012 |